MMJ PhytoTech Limited is pleased to note the attached three news releases by MediPharm Labs Inc (“MediPharm”) providing the details of three customer contracts signed over the past month or so and ahead of its listing on the TSX Venture Exchange (“TSX-V”) expected later this month.
Perth, Sep 5, 2018 - (ABN Newswire) - MMJ PhytoTech Limited (ASX:MMJ) (OTCMKTS:MMJJF) (“MMJ”) is pleased to note the attached three news releases by MediPharm Labs Inc (“MediPharm”) providing the details of three customer contracts signed over the past month or so and ahead of its listing on the TSX Venture Exchange (“TSX-V”) expected later this month.
MMJ’s CEO Jason Conroy said that “We are delighted to see the momentum building for MediPharm ahead of its listing on the TSX-V.”
MMJ owns approximately 6.9% of MediPharm.
To view the news releases, please visit:
http://abnnewswire.net/lnk/
WEB: MediPharm signs customer contracts ahead of TSX-V listing
About: MMJ PhytoTech Ltd
MMJ PhytoTech Limited (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ’s latest investor presentation and news, please visit: http://www.mmjphytotech.com.
